Casi pharmaceuticals announces partner juventas completes $65 million financing and initiates registration study for cnct19 (cd19 car-t)

Rockville, md. and beijing, nov. 18, 2020 /prnewswire/ -- casi pharmaceuticals, inc. (nasdaq: casi), a u.s. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announces partner juventas has completed the...
CASI Ratings Summary
CASI Quant Ranking